SBIR-STTR Award

Structure-based computational engineering of saCas9 PAM requirement
Award last edited on: 2/3/2024

Sponsored Program
SBIR
Awarding Agency
NIH : NIGMS
Total Award Amount
$274,955
Award Phase
1
Solicitation Topic Code
859
Principal Investigator
Xiaoqiang Huang

Company Information

ATGC Inc

35 Waltz Drive
Wheeling, IL 60090
   (800) 557-2248
   N/A
   www.acgtinc.com
Location: Multiple
Congr. District: 10
County: Cook

Phase I

Contract Number: 2023
Start Date: ----    Completed: 4/1/2023
Phase I year
2023
Phase I Amount
$274,955
SaCas9 is a major gene editing nuclease that is preferred for in vivo applications thanks to itsrelatively smaller size compared to that of spCas9. One limiting factor for the use of saCas9 isits strict PAM requirement of NNGRRT. In addition, there are limited efforts to reduce saCas9'soff-target editing rates. In Aim 1, we propose a computational approach to relax saCas9's PAMrequirement. We hypothesize that the interactions between key PAM recognition (KPR)residues of saCas9 and the side chains of PAM nucleotides determine the PAM requirement,and that mutating KPR residues by destroying their interactions with the DNA side chain whileintroducing favorable interactions with the DNA main chain will relax the PAM requirement. Wehave demonstrated the feasibility to relax the PAM requirement to NNNRRT in preliminary work.Here we will develop and optimize a computational method UniDesign to engineer saCas9s withfurther relaxed NNNRRN PAM (rr-saCas9s). In Aim 2, we propose to improve rr-saCas9'ssafety. Recently we reported the development of mispCas9, in which a small size (36 aminoacids) HDR (homology-directed repair)-promoting peptide Brex27 was fused to spCas9.Compared to spCas9, mispCas9 leads to increased knock-in rates as well as reduced off-targetinsertion and deletion (indel) events. Importantly, Brex27 can be used as a "plug and play"module to improve other gene-editing nucleases as long as their mechanism of action dependson the generation of double-strand breaks (DSB) of the genome. Here we will fuse Brex27 to rr-saCas9 (mirr-saCas9), and conduct experiments to characterize mirr-saCas9, in comparisonwith rr-saCas9 and saCas9, with a focus on PAM requirement, on-target editing efficacy, andoff-target rates. The proposed mirr-saCas9, if successful, will add favorable features to saCas9including: (i) 16 times more targetable sequences as a result of the relaxed PAM requirement(NNNRRN vs NNGRRT); and (ii) reduced off-target indel rates as a result of enhanced HDR atoff-target sites. Furthermore, the validated computational model is adaptable for theimprovement of other CRISPR variants for PAM modification and other desirable engineering.

Public Health Relevance Statement:
NARRATIVE SaCas9 is a major gene editing nuclease that is preferred for in vivo applications. Here we propose to develop a computational structural biology guided method UniDesign to engineer saCas9 with relaxed PAM requirement, and to improve saCas9's safety profile by fusing a small size HDR (homology-directed repair)-promoting peptide.

Project Terms:
<2019 novel corona virus><2019 novel coronavirus><2019-nCoV>

Phase II

Contract Number: 1R41GM149016-01A1
Start Date: 3/31/2024    Completed: 00/00/00
Phase II year
----
Phase II Amount
----